| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NI.3346 |
| P698 | PubMed publication ID | 26681461 |
| P2093 | author name string | Christoph Hess | |
| Glenn R Bantug | |||
| P2860 | cites work | Posttranscriptional control of T cell effector function by aerobic glycolysis | Q24606942 |
| The immune contexture in human tumours: impact on clinical outcome | Q29620667 | ||
| Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice | Q33824617 | ||
| Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer | Q34017104 | ||
| A central role for Notch in effector CD8(+) T cell differentiation | Q34517022 | ||
| T cell metabolic fitness in antitumor immunity | Q35371293 | ||
| Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. | Q36054460 | ||
| Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. | Q36386431 | ||
| MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta | Q39703169 | ||
| Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression | Q41437712 | ||
| Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch | Q42275889 | ||
| The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells | Q44997676 | ||
| Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer | Q57152489 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 41-42 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Glycolysis and EZH2 boost T cell weaponry against tumors | |
| P478 | volume | 17 |
Search more.